Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13290-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13290-1-AP, RRID:AB_10597852
- Product name
- RNF125 antibody
- Antibody type
- Polyclonal
- Description
- RNF125 antibody (Cat. #13290-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references RNF125 promotes CD8 T cell-mediated anticancer immunity and suppresses the malignant phenotype of cervical cancer.
PRRSV GP2a blocks the RLR signaling pathway by targeting RIG-I.
RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125.
RNF125‑mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells.
RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.
Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner.
Yang D, Liu J, Gao Y, Guan X, Tong R
Molecular and cellular biochemistry 2026 May;481(5):2005-2020
Molecular and cellular biochemistry 2026 May;481(5):2005-2020
PRRSV GP2a blocks the RLR signaling pathway by targeting RIG-I.
Xiang Y, Mou C, Zhao X, Zhuo C, Shi K, Go YY, Chen Z
Journal of virology 2025 Nov 25;99(11):e0113525
Journal of virology 2025 Nov 25;99(11):e0113525
RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125.
Yan Y, Kong X, Jin X, Bu J, Ni B, Rao Z, Guo J, Xu S
Oncology reports 2025 Jul;54(1)
Oncology reports 2025 Jul;54(1)
RNF125‑mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells.
Feng X, Song D, Liu X, Liang Y, Jiang P, Wu S, Liu F
Oncology letters 2024 Mar;27(3):105
Oncology letters 2024 Mar;27(3):105
RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.
Feng Z, Ke S, Wang C, Lu S, Xu Y, Yu H, Li Z, Yin B, Li X, Hua Y, Qian B, Bai M, Fu Y, Zhang Y, Wu Y, Ma Y
Oncogene 2023 Jun;42(24):2017-2030
Oncogene 2023 Jun;42(24):2017-2030
Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner.
Kong X, Lu X, Wang S, Hao J, Guo D, Wu H, Jiang Y, Sun Y, Wang J, Zhang G, Cai Z
Cell reports 2023 Jan 31;42(1):112002
Cell reports 2023 Jan 31;42(1):112002
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- mouse spleen tissue were subjected to SDS PAGE followed by western blot with 13290-1-AP(RNF125 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The RNF125 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human RNF125. This antibody recognizes human,mouse,rat antigen. The RNF125 antibody has been validated for the following applications: ELISA, WB, IHC analysis.